The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

The imminent Indian patent expiry of Novo Nordisk’s global blockbuster anti-diabetic and weight loss treatment drug – the GLP ...

An RN shares 7 signs your Ozempic dose may be too low or too high, plus daily habits that can improve results.

The average participant getting a 12-mg weekly injection lost 71 pounds in 68 weeks.  "This is beyond what we see with any ...

Medicare enrollees will save more than 50% on out-of-pocket costs for 10 common prescription drugs under their insurance ...

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from ...

Eli Lilly ( LLY 1.19%) and Novo Nordisk ( NVO 2.44%) are two of the leading companies in the fast-growing GLP-1 weight loss ...

For the last installment of the America in Focus project this year, we spoke with 14 Americans from all walks of life who are ...

Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of ...

Policy swings have made it a slippery year for pharma ...

The whole series has been a real joy to follow this year — not something you can always say about constantly shifting health care news. Watch some of the previous videos here. Republicans in Congress ...